Li Wen, Liu Juan, Ji Li, Tang Yi, Qin Jianbing, Zhao Heyan, Cheng Xiang, Tian Meiling, Jin Guohua, He Hui
Department of Human Anatomy, Medical School, Nantong University, Nantong, Jiangsu, People's Republic of China.
Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Nantong, Jiangsu, People's Republic of China.
Neurochem Res. 2022 Mar;47(3):679-691. doi: 10.1007/s11064-021-03476-x. Epub 2021 Nov 15.
Glioma multiforme (GBM) is the most common malignant primary brain tumors. Despite the considerable advances in GBM treatment, it is still one of the most lethal forms of brain tumor. New clinical biomarkers and therapeutic targets are immediately required. MicroRNAs (miRNAs) are a class of small, evolutionarily conserved noncoding RNAs and have emerged as the key regulators of many cancers. Here in this study, we showed that miR-674-5p was probably an important regulator of glioma cell growth. After the transfection with miR-674-5p mimic or inhibitor, we found that the expression level of miR-674-5p was negatively related with cell proliferation and migration in C6 cells. Based on the prediction of the target genes of miR-674-5p on the website, we chose Cullin 4B (Cul4b), a gene upregulated in GBM, and proved that it was a target of miR-674-5p. In addition, we explored the role of miR-674-5p in glioma growth in vivo. Taken together, the present study indicated that miR-674-5p suppressed glioma cell proliferation and migration by targeting Cul4b.
多形性胶质母细胞瘤(GBM)是最常见的原发性恶性脑肿瘤。尽管GBM治疗取得了显著进展,但它仍然是最致命的脑肿瘤形式之一。当下迫切需要新的临床生物标志物和治疗靶点。微小RNA(miRNA)是一类小的、进化上保守的非编码RNA,已成为许多癌症的关键调节因子。在本研究中,我们表明miR-674-5p可能是胶质瘤细胞生长的重要调节因子。在用miR-674-5p模拟物或抑制剂转染后,我们发现miR-674-5p的表达水平与C6细胞中的细胞增殖和迁移呈负相关。基于在网站上对miR-674-5p靶基因的预测,我们选择了在GBM中上调的基因Cullin 4B(Cul4b),并证明它是miR-674-5p的一个靶点。此外,我们还探讨了miR-674-5p在体内胶质瘤生长中的作用。综上所述,本研究表明miR-674-5p通过靶向Cul4b抑制胶质瘤细胞的增殖和迁移。